Vineet Laboratories Limited (VINEETLAB) — Financial Results
· NSE
🔴 High Importance
Neutral
Net Profit: ₹87.22
📢 Key Event
Trading window closed for insiders ahead of Q4 results announcement
💡 Investor Takeaway
Shareholders should note insider trading restrictions are now in effect before financial results are released.
Vineet Laboratories Limited reported a 69.9% YoY revenue increase to ₹87.22 crores for the quarter, driven by strong performance in its key segments. The company also disclosed a new regulatory trading window closure for insiders ahead of its audited financial results announcement.
About Vineet Laboratories Limited (VINEETLAB)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
Market Cap: ₹74.04 Cr
Recent Announcements from Vineet Laboratories Limited
-
🔴 Financial Results — 11 July 2026
Vineet Laboratories Limited announced that its board will meet on July 15, 2026 to approve audited standalone financial results for the quarter and ye... -
🔴 Announcement — 24 June 2026
No summary available -
🟡 Board Meeting — 30 May 2026
No summary available -
🔴 Financial Results — 30 May 2026
Vineet Laboratories announced on May 30, 2026 that its board meeting was postponed, deferring consideration of the audited standalone financial result... -
🔴 Corporate Action — 15 May 2026
Vineet Laboratories Limited disclosed its Crisil Ratings Monitoring Agency Report for the quarter ended March 31, 2026, detailing utilization of funds...
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when VINEETLAB files new disclosures
Track VINEETLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track VINEETLAB — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research